Gilead signs sales deal with Glaxo for Viread (AP)
Gilead Sciences, GlaxoSmithKline sign deal to sell Viread as hepatitis B drug in Asia NEW YORK (AP) -- Gilead Sciences Inc. and GlaxoSmithKline said Tuesday they signed a deal to sell Viread as a hepatitis B treatment in Asia....


